Lacutamab
Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma[1].
Product Specifications
CAS Number
[2187368-16-5]
Product Name Alternative
IPH 4102; Anti-KIR3DL2/CD158k Reference Antibody (lacutamab)
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lacutamab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Lacutamab]
Molecular Weight
(144.52 kDa)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99369/Lacutamab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99369/Lacutamab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rat Pulmonary surfatcant-associated protein B, SP-A ELISA Kit
Rat Pulmonary surfatcant-associated protein B, SP-A ELISA Kit